Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cai, J.
Right arrow Articles by Gill, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cai, J.
Right arrow Articles by Gill, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Glucocorticoids induce Kaposi's sarcoma cell proliferation through the regulation of transforming growth factor-beta

J Cai, T Zheng, M Lotz, Y Zhang, R Masood and P Gill

Department of Internal Medicine, University of Southern California School of Medicine, Los Angeles, USA.

Glucocorticoid (GC) use is known to induce or enhance the growth of Kaposi's sarcoma (KS) in many clinical settings including human immunodeficiency virus infection, collagen vascular disease, lymphoproliferative disorders, and renal transplantation. Because GCs may induce immune suppression and thus tumor growth, we determined whether GCs had a direct effect on KS growth. We found that GCs directly induce the growth of KS cell lines. In examining the mechanism of action of GCs, we did not observe induction of known autocrine growth factors for KS including interleukin-1 (IL-1), IL-6, oncostatin- M, basic fibroblast growth factor (bFGF), and vascular endothelial growth factor (VEGF). We thus examined factor(s) that inhibit KS growth. Transforming growth factor-beta (TGF-beta) is produced by KS cells and has pleiotropic effects, including inhibiting the growth of hematopoietic and endothelial cells. We show that TGF-beta is produced by KS cells in both the latent and active forms, and that TGF-beta is an autocrine growth inhibitory factor. We then studied the effects of GCs on the regulation of TGF-beta and found that GCs do not inhibit TGF- beta transcription, but significantly inhibit TGF-beta activation. This effect is mediated through regulation of the TGF-beta activation pathway. TGF-beta is activated by plasmin which is positively regulated by plasminogen activator (PA) and PA receptor (PAR), and negatively regulated by plasminogen activator inhibitor (PAI). GCs downregulated PAR and upregulated PAI. Thus, glucocorticoids enhance KS cell growth through the regulation of TGF-beta activation.

Volume 89, Issue 5, pp. 1491-1500, 03/01/1997
Copyright © 1997 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
R. Masood, J. Cai, A. Tulpule, T. Zheng, A. Hamilton, S. Sharma, B. M. Espina, D. L. Smith, and P. S. Gill
Interleukin 8 Is an Autocrine Growth Factor and a Surrogate Marker for Kaposi's Sarcoma
Clin. Cancer Res., September 1, 2001; 7(9): 2693 - 2702.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Masood, S. Nagpal, T. Zheng, J. Cai, A. Tulpule, D. L. Smith, and P. S. Gill
Kaposi sarcoma is a therapeutic target for vitamin D3 receptor agonist
Blood, November 1, 2000; 96(9): 3188 - 3194.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Kojima, S. Hayashi, K. Shimokado, Y. Suzuki, J. Shimada, M. P. Crippa, and S. L. Friedman
Transcriptional activation of urokinase by the Kruppel-like factor Zf9/COPEB activates latent TGF-beta 1 in vascular endothelial cells
Blood, February 15, 2000; 95(4): 1309 - 1316.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
Q. Hasan, S. T. Tan, J. Gush, S. G. Peters, and P. F. Davis
Steroid Therapy of a Proliferating Hemangioma: Histochemical and Molecular Changes
Pediatrics, January 1, 2000; 105(1): 117 - 120.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Aoki and G. Tosato
Role of Vascular Endothelial Growth Factor/Vascular Permeability Factor in the Pathogenesis of Kaposi's Sarcoma-Associated Herpesvirus-Infected Primary Effusion Lymphomas
Blood, December 15, 1999; 94(12): 4247 - 4254.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Masood, M. E. McGarvey, T. Zheng, J. Cai, N. Arora, D. L. Smith, N. Sloane, and P. S. Gill
Antineoplastic Urinary Protein Inhibits Kaposi's Sarcoma and Angiogenesis In Vitro and In Vivo
Blood, February 1, 1999; 93(3): 1038 - 1044.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. S. Gill, Y. C. Tsai, A. P. Rao, C. H. Spruck III, T. Zheng, W. A. Harrington Jr., T. Cheung, B. Nathwani, and P. A. Jones
Evidence for multiclonality in multicentric Kaposi's sarcoma
PNAS, July 7, 1998; 95(14): 8257 - 8261.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 1997 by American Society of Hematology         Online ISSN: 1528-0020